Pacira | Kostnadene For Salg



Cost Of Sales Endring Dato
Astellas Pharma JPY 98.52B 15.83B 2024-12
Bristol-Myers Squibb USD 3.21B 356M 2024-12
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
J&J USD 7.11B 151M 2024-12
Ligand Pharmaceuticals USD 2.84M 388K 2024-12
Novo Nordisk 11.31B 1.03B 2024-09
Pacira USD 39.89M 1.02M 2024-12
Perrigo USD 752.4M 69.3M 2024-12
Pfizer USD 5.65B 781M 2024-12
Supernus Pharmaceuticals USD 17.2M 385K 2024-12
Teva Pharmaceutical Industries USD 2.11B 18M 2024-12
Xeris Pharmaceuticals USD 9.48M 4.12M 2024-12
Zoetis USD 707M 8M 2024-12



Pacira Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.